Literature DB >> 19517115

[Usher syndrome: clinical features, diagnostic options, and therapeutic prospects].

M W Seeliger1, M D Fischer, M Pfister.   

Abstract

Usher syndrome denotes a clinically and genetically heterogeneous combination of retinitis pigmentosa and sensorineural deafness. The division into subtypes I, II, and III is based on the degree of hearing loss: Type I is characterized by deafness from birth together with ataxia and retarded motor development, type II by a stationary deafness of a moderate degree, and type III by a progressive deafness with adult onset. In Germany, Usher syndrome currently bears particular relevance because in January 2009 a new compulsory screening of auditory function in newborn infants was introduced. Consequently, it can be expected that a higher number of patients with Usher syndrome will be identified in early childhood and referred to ophthalmologists. The focus of this work is to introduce the typical clinical picture of Usher syndrome, summarize diagnostic options, and give an overview of therapeutic strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19517115     DOI: 10.1007/s00347-008-1888-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  18 in total

Review 1.  Usher syndrome: molecular links of pathogenesis, proteins and pathways.

Authors:  Hannie Kremer; Erwin van Wijk; Tina Märker; Uwe Wolfrum; Ronald Roepman
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

Review 2.  Update on Usher syndrome.

Authors:  Zubin Saihan; Andrew R Webster; Linda Luxon; Maria Bitner-Glindzicz
Journal:  Curr Opin Neurol       Date:  2009-02       Impact factor: 5.710

3.  Multifocal electroretinography in retinitis pigmentosa.

Authors:  M Seeliger; U Kretschmann; E Apfelstedt-Sylla; K Rüther; E Zrenner
Journal:  Am J Ophthalmol       Date:  1998-02       Impact factor: 5.258

4.  Quality of life and cochlear implantation in Usher syndrome type I.

Authors:  Godelieve W J A Damen; Ronald J E Pennings; Ad F M Snik; Emmanuel A M Mylanus
Journal:  Laryngoscope       Date:  2006-05       Impact factor: 3.325

5.  Audiologic performance and benefit of cochlear implantation in Usher syndrome type I.

Authors:  Ronald J E Pennings; Godelieve W J A Damen; Ad F M Snik; Lies Hoefsloot; Cor W R J Cremers; Emmanuel A M Mylanus
Journal:  Laryngoscope       Date:  2006-05       Impact factor: 3.325

6.  The frequency of posterior subcapsular cataract in the hereditary retinal degenerations.

Authors:  J Heckenlively
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

Review 7.  The retinal ciliopathies.

Authors:  N A Adams; Ahmed Awadein; Hassanain S Toma
Journal:  Ophthalmic Genet       Date:  2007-09       Impact factor: 1.803

Review 8.  Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.

Authors:  Jan Reiners; Kerstin Nagel-Wolfrum; Karin Jürgens; Tina Märker; Uwe Wolfrum
Journal:  Exp Eye Res       Date:  2006-03-20       Impact factor: 3.467

9.  Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Tomas S Aleman; Alexander Sumaroka; Alejandro J Roman; Leigh M Gardner; Haydn M Prosser; Monalisa Mishra; N Torben Bech-Hansen; Waldo Herrera; Sharon B Schwartz; Xue-Zhong Liu; William J Kimberling; Karen P Steel; David S Williams
Journal:  Hum Mol Genet       Date:  2008-05-07       Impact factor: 6.150

10.  Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B.

Authors:  T Hashimoto; D Gibbs; C Lillo; S M Azarian; E Legacki; X-M Zhang; X-J Yang; D S Williams
Journal:  Gene Ther       Date:  2007-02-01       Impact factor: 4.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.